MannKind Corporation - Common Stock — Quarterly Financial Statistics (NASDAQ:MNKD) | MetaTrader

Open full chart

Financials

Overview Statement Statistics

Quarterly Annual

Cash from operating activities -6.38 M8.95 M23.64 M-7.96 M-5.37 M 19.27 M Cash from investing activities 5.96 M6.26 M-25.06 M-291.96 M18.73 M -292.04 M Cash from financing activities 1.39 M-5.51 M71.81 M247.41 M-35.41 M 278.3 M Free cash flow -6.38 M8.95 M23.64 M-7.96 M-5.37 M 19.27 M

News

MannKind At An Inflection Point: Pediatric Expansion Drives The Story (NASDAQ:MNKD)

MannKind Corporation (MNKD) Discusses FDA Approval of Afrezza for Pediatric Diabetes Patients Ages 6 and Older Transcript

Compared to Estimates, MannKind (MNKD) Q1 Earnings: A Look at Key Metrics

MannKind (MNKD) Reports Q1 Loss, Misses Revenue Estimates

Agios Pharmaceuticals (AGIO) Reports Q1 Loss, Tops Revenue Estimates

MannKind: Strategic Uncertainty Follows United Therapeutics’ Pivot (NASDAQ:MNKD)

MannKind at Barclays Healthcare Conference: Strategic Growth and Innovation

MannKind Corporation (MNKD) Presents at Barclays 28th Annual Global Healthcare Conference Transcript

MannKind at Leerink Global Healthcare: Expanding Horizons in Pharma

MannKind presents Afrezza data at diabetes conference

MannKind settles $36.3M convertible notes with cash, shares

H.C. Wainwright cuts MannKind stock price target on Tyvaso outlook